Evidence map›Paper›PMID 39920787›Full record

ArticleItalian journal of pediatrics2025

Drug response is related to NR3C1 and FAAH polymorphism in Chinese pediatric epilepsy patients.

Hongli Wang, Chu Li, Qian Li, Ning Li, Huiling Qin

Abstract read
In one paragraph

Article in Italian journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hongli Wang *Department of Paediatric, Affiliated Hospital of Chengdu University, Chengdu, 610081, China.
Chu Li *The First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.
Qian LiDepartment of Paediatric, Dongying People's Hospital, No. 317, Dongcheng South 1 Road, Dongying, 257091, China. liqiandr@163.com.
Ning LiDepartment of Surgery, Guangrao County Traditional Chinese Medicine Hospital, Dongying, 257399, China.
Huiling QinDepartment of Rehabilitation Medicine, The Affiliated Hospital of Youjiang Medical University for Nationalities, No. 18, Zhongshan 2 Road, Youjiang District, Baise, 533000, China. qinhuiling533000@163.com.ORCID http://orcid.org/0009-0004-7103-474X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChildhood epilepsy is a common neurological syndrome with complex etiology and recurrent seizures. It seriously affects the growth and development of child patients.

methodsNR3C1 rs41423247 and FAAH rs324420 polymorphisms were detected by the polymerase chain reaction in 105 pediatric epilepsy patients. Patients were divided into the good response group and the poor response group after anti-seizure medications (ASMs) treatment. According to the results of the liver function test (LFT), patients were divided into the no LFT disturbance group and the LFT disturbance group. Hardy-Weinberg balance was applied to analyze the population representation. The correlations were calculated by logistic regression analysis.

resultsNR3C1 rs41423247 genotype and allele frequencies differed significantly between good response and poor response groups, while FAAH rs324420 did not. The CG genotype and C allele of NR3C1 rs41423247 were associated with good drug response, and the association was also detected in the dominant model. In addition, polymorphisms in NR3C1 and FAAH were not associated with liver damage induced by epilepsy medication.

conclusionThe polymorphism of NR3C1 rs41423247 might influence the drug response of epilepsy children.

Indexed as

AmidohydrolasesAnticonvulsantsEpilepsyAdolescentChildChild, PreschoolChinaEast Asian PeopleFatty Acid Amide HydrolasesFemaleGenotypeHumansMalePolymorphism, GeneticPolymorphism, Single NucleotideReceptors, GlucocorticoidAmidohydrolasesAnticonvulsantsFatty Acid Amide HydrolasesNR3C1 protein, humanReceptors, GlucocorticoidDrug responseEpilepsyFAAH rs324420Liver dysfunctionNR3C1 rs41423247

Identifiers

PMID39920787
PMCPMC11803932

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.